CoverageForm 410-K10-Q8-K13D13G13F

PHYT Pyrophyte Acquisition Corp. - 8-K

Filed Apr 21, 2026. See issuer overview · financials · original on SEC.gov ↗
Accession
0001213900-26-046253
8.01

Item 8.01 - Other Events

733 words

Item 8.01. Other Events.

As previously disclosed, on April 25, 2025, Pyrophyte
Acquisition Corp. (the “ Company ”) held an extraordinary general meeting of shareholders to approve an extension
of the time by which it had to consummate its initial business combination from April 29, 2025 to April 29, 2026 (the “ Third
Extension ”). In connection with the Extension, Pyrophyte Acquisition LLC (the “ Sponsor ”), agreed
that it or its designee would deposit into the Company’s trust account (the “ Trust Account ”) an amount
equal to $75,697.70 on a monthly basis through the Extension (the “ Extension Amount ”).

On April 21, 2026, the
Sponsor caused the Extension Amount to be deposited into the Trust Account for each of the tenth, eleventh and twelfth months of the
Third Extension totaling $227,093.10, plus interest with respect to the aforementioned payments in the amount of $3,782.71.

Additional Information
and Where to Find It

The
Company has filed a definitive proxy statement (the “ Extension Proxy Statement ”) to be used at in connection
with an extraordinary general meeting of its shareholders to approve, among other things, an extension of time in which the Company must
complete an initial business combination (the “ Fourth Extension ”). The Company urges investors, shareholders
and other interested persons to read the definitive proxy statement dated April 8, 2026 relating to the Fourth Extension (the “ Extension
Proxy Statement ”), as well as other documents filed by the Company with the U.S. Securities and Exchange Commission (the
“ SEC ”), because these documents contain important information about the Company and the Fourth Extension. The
Extension Proxy Statement was mailed to shareholders of the Company as of a record date of March 27, 2026, on or about April 9, 2026.
Shareholders may obtain copies of the Extension Proxy Statement, without charge, at the SEC’s website at  www.sec.gov  or
by directing a request to: 3262 Westheimer Road, Suite 706, Houston, Texas 77098, Attention: Sten Gustafson, Chief Financial Officer.

Participants in Solicitation

The
Company and its directors, executive officers and other members of their management may be deemed to be participants in the solicitation
of proxies of the Company’s shareholders in connection with the proposals described therein. Investors and security holders may
obtain more detailed information regarding the names, affiliations and interests of the Company’s directors and officers in the
Extension Proxy Statement, which may be obtained free of charge from the sources indicated above.

Non-Solicitation

This
communication is not a proxy statement or solicitation of a proxy, consent or authorization with respect to any securities or in respect
of the Fourth Extension and shall not constitute an offer to sell or a solicitation of an offer to buy the securities of the Company,
nor shall there be any sale of any such securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful
prior to registration or qualification under the securities laws of such state or jurisdiction. No offer of securities shall be made except
by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

Forward Looking Statements

This
communication includes forward-looking statements that involve risks and uncertainties. Forward-looking statements are statements that
are not historical facts. Such forward-looking statements are subject to risks and uncertainties, to which could cause actual results
to differ from the forward-looking statements. These forward-looking statements and factors that may cause such differences include, without
limitation, uncertainties relating the Company’s shareholder approval of the Fourth Extension, the Company’s inability to
complete an initial business combination within the required time period, and other risks and uncertainties indicated from time to time
in filings with the SEC, including the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024 under the
heading “ Risk Factors ,” the Extension Proxy Statement under the heading “ Risk Factors ” and other
documents the Company has filed, or to be filed, with the SEC. Readers are cautioned not to place undue reliance upon any forward-looking
statements, which speak only as of the date made. The Company expressly disclaims any obligations or undertaking to release publicly any
updates or revisions to any forward-looking statements contained herein to reflect any change in the Company’s expectations with
respect thereto or any change in events, conditions or circumstances on which any statement is based.

1